Showing results (131-140 of 334) with videos related to

Sort By:
Pageof 34
Advances in Experimental Medicine and Biology|January 1, 1979
Effect of immune sera upon enhanced in vitro antibody responsesS J Frank, S Specter, A Nowotny, et al.
Seminars in Immunology|March 1, 1990
The structure and signalling functions of the invariant T cell receptor componentsS J Frank, L E Samelson, R D Klausner
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|March 27, 2012
Horseshoe tract of anal fistula: bad luck or an avoidable extension? Lessons from 82 casesV de Parades, N Fathallah, P Blanchard, et al.
Annals of the New York Academy of Sciences|November 18, 2000
Fluorometric high-throughput screening for inhibitors of cytochrome P450V P Miller, D M Stresser, A P Blanchard, et al.
Diabetes Research and Clinical Practice|December 16, 1994
Minimal model for determination of insulin sensitivity: repeatability in control and obese subjectsM Krempf, I Got, O Ziegler, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 13, 2013
[High dose rate prostate brachytherapy]P Nickers, P Blanchard, J-M Hannoun-Lévi, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 10, 2012
[Involved-node radiotherapy combined with deep-inspiration breath-hold technique in patients with Hodgkin lymphoma]A Paumier, M Bakkour, M Ghalibafian, et al.
Bioelectromagnetics|January 1, 1996
Magnetic fields at resonant conditions for the hydrogen ion affect neurite outgrowth in PC-12 cells: a test of the ion parametric resonance modelM A Trillo, A Ubeda, J P Blanchard, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 9, 2021
[Dosimetric impact of hydrogel spacer use for stereotactic body radiotherapy of localised prostate cancer]M Ung, A Bossi, L Abbassi, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 24, 2023
Management of head and neck carcinomas with synchronous or metachronous oligometastatic disease: Role of locoregional radiotherapy and metastasis-directed radiotherapyM Tonneau, R Nebbache, A Larnaudie, et al.
Pageof 34